Our carefully researched speaker programmes are further enhanced by the opportunity for the delegates and speakers to discuss topics of interest in more detail during panel and round table discussions. This means that the attendees not only benefit from the expertise of the high level speaker panel but also that of the other delegates.

If you have a cutting edge case study or a presentation and would like to join the speaker panel at one of our events, please contact Mike Burden at m.burden@oxfordglobal.co.uk

2010 Advisory Panel Includes:

·         Zoran Rankovic, Associate Director Medicinal Chemistry, Schering Plough

·         Ted Torphy, Chief Scientific Officer and Head, External Research & Early Development, Johnson & Johnson

·         Malcolm Weir, Chief Executive Officer, Heptares Therapeutics

·         Jonathan Mason, Chief Scientist, Predictive Technology & Drug Design, Lundbeck Research / Design for Drug Discovery

·         Craig Johnstone, Associate Director of Chemistry, Cardiovascular & Gastrointestinal Discovery, AstraZeneca

·         Lex Van der Ploeg, Senior Vice President, Integrative Medicine and Translational Science, Abraxis Bioscience

·         John Haurum, Chief Scientific Officer, Symphogen A/S

·         Per Källblad, Chief Executive Officer, Beactica

·         Rod Hubbard, Research Fellow, Vernalis & Structural Biology Lab, University of York

·         Patrice Talaga, Director, Chemistry Outsourcing, UCB

·         Doriano Fabbro, Head of Kinase Biology, Expertise Platform Kinases, Center for Proteomic Chemistry Novartis

·         Johan Luthman,  CEO, GeNeuro S.A

·         Stevan Djuric, Senior Director, Medicinal Chemistry Technologies, Abbott

·         Martin Klumpp, Lab Head Assay Development and Screening, Novartis